Challenges in access to oncology medicines: Policies and practices across the OECD and the EU
With rapid advancements in oncology, even the wealthiest countries around the globe find it increasingly challenging to provide - and sustain - access to new medicines. Challenges include managing the uncertainty surrounding the extent of benefit of new treatments; complexities in determining the pr...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Paris
OECD Publishing
2020
|
| Schriftenreihe: | OECD Health Working Papers
no.123 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | With rapid advancements in oncology, even the wealthiest countries around the globe find it increasingly challenging to provide - and sustain - access to new medicines. Challenges include managing the uncertainty surrounding the extent of benefit of new treatments; complexities in determining the price and place in therapy of certain products; and the need to reconcile affordable, equitable access with spending efficiency and fiscal sustainability. Differences in timing of market entry and heterogeneity of coverage processes and policies contribute to inequity in access across the OECD and EU. Future policies and practices to promote sustainable access to oncology medicines will likely focus on improving affordability for patients and value-for-money for payers. An important element will be strengthening the evidence base, drawing on both clinical trial and "real world" evidence, and enhancing international collaboration and information sharing to improve countries' collective capacity to address clinical and economic uncertainties. |
| Beschreibung: | 1 Online-Ressource (108 p.) |
| DOI: | 10.1787/4b2e9cb9-en |
Internformat
MARC
| LEADER | 00000cam a22000002 4500 | ||
|---|---|---|---|
| 001 | ZDB-13-SOC-061235563 | ||
| 003 | DE-627-1 | ||
| 005 | 20231204121228.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210204s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1787/4b2e9cb9-en |2 doi | |
| 035 | |a (DE-627-1)061235563 | ||
| 035 | |a (DE-599)KEP061235563 | ||
| 035 | |a (FR-PaOEC)4b2e9cb9-en | ||
| 035 | |a (EBP)061235563 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a L11 |2 jelc | ||
| 084 | |a I11 |2 jelc | ||
| 084 | |a I13 |2 jelc | ||
| 084 | |a I14 |2 jelc | ||
| 084 | |a I18 |2 jelc | ||
| 084 | |a H51 |2 jelc | ||
| 100 | 1 | |a Chapman, Suzannah |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Challenges in access to oncology medicines |b Policies and practices across the OECD and the EU |c Suzannah, Chapman, Valérie, Paris and Ruth, Lopert |
| 264 | 1 | |a Paris |b OECD Publishing |c 2020 | |
| 300 | |a 1 Online-Ressource (108 p.) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a OECD Health Working Papers |v no.123 | |
| 520 | |a With rapid advancements in oncology, even the wealthiest countries around the globe find it increasingly challenging to provide - and sustain - access to new medicines. Challenges include managing the uncertainty surrounding the extent of benefit of new treatments; complexities in determining the price and place in therapy of certain products; and the need to reconcile affordable, equitable access with spending efficiency and fiscal sustainability. Differences in timing of market entry and heterogeneity of coverage processes and policies contribute to inequity in access across the OECD and EU. Future policies and practices to promote sustainable access to oncology medicines will likely focus on improving affordability for patients and value-for-money for payers. An important element will be strengthening the evidence base, drawing on both clinical trial and "real world" evidence, and enhancing international collaboration and information sharing to improve countries' collective capacity to address clinical and economic uncertainties. | ||
| 650 | 4 | |a Social Issues/Migration/Health | |
| 700 | 1 | |a Paris, Valérie |e MitwirkendeR |4 ctb | |
| 700 | 1 | |a Lopert, Ruth |e MitwirkendeR |4 ctb | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-13-SOC |q FWS_PDA_SOC |u https://doi.org/10.1787/4b2e9cb9-en |3 Volltext |
| 912 | |a ZDB-13-SOC | ||
| 912 | |a ZDB-13-SOC | ||
| 951 | |a BO | ||
| 912 | |a ZDB-13-SOC | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-13-SOC-061235563 |
|---|---|
| _version_ | 1816797344866238464 |
| adam_text | |
| any_adam_object | |
| author | Chapman, Suzannah |
| author2 | Paris, Valérie Lopert, Ruth |
| author2_role | ctb ctb |
| author2_variant | v p vp r l rl |
| author_facet | Chapman, Suzannah Paris, Valérie Lopert, Ruth |
| author_role | aut |
| author_sort | Chapman, Suzannah |
| author_variant | s c sc |
| building | Verbundindex |
| bvnumber | localFWS |
| collection | ZDB-13-SOC |
| ctrlnum | (DE-627-1)061235563 (DE-599)KEP061235563 (FR-PaOEC)4b2e9cb9-en (EBP)061235563 |
| discipline | Wirtschaftswissenschaften |
| doi_str_mv | 10.1787/4b2e9cb9-en |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02402cam a22004332 4500</leader><controlfield tag="001">ZDB-13-SOC-061235563</controlfield><controlfield tag="003">DE-627-1</controlfield><controlfield tag="005">20231204121228.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210204s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/4b2e9cb9-en</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627-1)061235563</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KEP061235563</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(FR-PaOEC)4b2e9cb9-en</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EBP)061235563</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">L11</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">I11</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">I13</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">I14</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">I18</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">H51</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chapman, Suzannah</subfield><subfield code="e">VerfasserIn</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Challenges in access to oncology medicines</subfield><subfield code="b">Policies and practices across the OECD and the EU</subfield><subfield code="c">Suzannah, Chapman, Valérie, Paris and Ruth, Lopert</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (108 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OECD Health Working Papers</subfield><subfield code="v">no.123</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">With rapid advancements in oncology, even the wealthiest countries around the globe find it increasingly challenging to provide - and sustain - access to new medicines. Challenges include managing the uncertainty surrounding the extent of benefit of new treatments; complexities in determining the price and place in therapy of certain products; and the need to reconcile affordable, equitable access with spending efficiency and fiscal sustainability. Differences in timing of market entry and heterogeneity of coverage processes and policies contribute to inequity in access across the OECD and EU. Future policies and practices to promote sustainable access to oncology medicines will likely focus on improving affordability for patients and value-for-money for payers. An important element will be strengthening the evidence base, drawing on both clinical trial and "real world" evidence, and enhancing international collaboration and information sharing to improve countries' collective capacity to address clinical and economic uncertainties.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social Issues/Migration/Health</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Paris, Valérie</subfield><subfield code="e">MitwirkendeR</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lopert, Ruth</subfield><subfield code="e">MitwirkendeR</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="q">FWS_PDA_SOC</subfield><subfield code="u">https://doi.org/10.1787/4b2e9cb9-en</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">BO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-13-SOC-061235563 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-26T14:56:05Z |
| institution | BVB |
| language | English |
| open_access_boolean | |
| owner | DE-863 DE-BY-FWS |
| owner_facet | DE-863 DE-BY-FWS |
| physical | 1 Online-Ressource (108 p.) |
| psigel | ZDB-13-SOC |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | OECD Publishing |
| record_format | marc |
| series2 | OECD Health Working Papers |
| spelling | Chapman, Suzannah VerfasserIn aut Challenges in access to oncology medicines Policies and practices across the OECD and the EU Suzannah, Chapman, Valérie, Paris and Ruth, Lopert Paris OECD Publishing 2020 1 Online-Ressource (108 p.) Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier OECD Health Working Papers no.123 With rapid advancements in oncology, even the wealthiest countries around the globe find it increasingly challenging to provide - and sustain - access to new medicines. Challenges include managing the uncertainty surrounding the extent of benefit of new treatments; complexities in determining the price and place in therapy of certain products; and the need to reconcile affordable, equitable access with spending efficiency and fiscal sustainability. Differences in timing of market entry and heterogeneity of coverage processes and policies contribute to inequity in access across the OECD and EU. Future policies and practices to promote sustainable access to oncology medicines will likely focus on improving affordability for patients and value-for-money for payers. An important element will be strengthening the evidence base, drawing on both clinical trial and "real world" evidence, and enhancing international collaboration and information sharing to improve countries' collective capacity to address clinical and economic uncertainties. Social Issues/Migration/Health Paris, Valérie MitwirkendeR ctb Lopert, Ruth MitwirkendeR ctb FWS01 ZDB-13-SOC FWS_PDA_SOC https://doi.org/10.1787/4b2e9cb9-en Volltext |
| spellingShingle | Chapman, Suzannah Challenges in access to oncology medicines Policies and practices across the OECD and the EU Social Issues/Migration/Health |
| title | Challenges in access to oncology medicines Policies and practices across the OECD and the EU |
| title_auth | Challenges in access to oncology medicines Policies and practices across the OECD and the EU |
| title_exact_search | Challenges in access to oncology medicines Policies and practices across the OECD and the EU |
| title_full | Challenges in access to oncology medicines Policies and practices across the OECD and the EU Suzannah, Chapman, Valérie, Paris and Ruth, Lopert |
| title_fullStr | Challenges in access to oncology medicines Policies and practices across the OECD and the EU Suzannah, Chapman, Valérie, Paris and Ruth, Lopert |
| title_full_unstemmed | Challenges in access to oncology medicines Policies and practices across the OECD and the EU Suzannah, Chapman, Valérie, Paris and Ruth, Lopert |
| title_short | Challenges in access to oncology medicines |
| title_sort | challenges in access to oncology medicines policies and practices across the oecd and the eu |
| title_sub | Policies and practices across the OECD and the EU |
| topic | Social Issues/Migration/Health |
| topic_facet | Social Issues/Migration/Health |
| url | https://doi.org/10.1787/4b2e9cb9-en |
| work_keys_str_mv | AT chapmansuzannah challengesinaccesstooncologymedicinespoliciesandpracticesacrosstheoecdandtheeu AT parisvalerie challengesinaccesstooncologymedicinespoliciesandpracticesacrosstheoecdandtheeu AT lopertruth challengesinaccesstooncologymedicinespoliciesandpracticesacrosstheoecdandtheeu |